ABBVIE INC. vs. Viking Therapeutics, Inc
ABBVIE INC. (ABBV) comes out ahead, leading on 2 of 2 compared factors.
Size & Scale
| ABBV | VKTX | |
|---|---|---|
| Market Cap | $430.82 billion | $3.91 billion |
| Revenue (TTM) | — | — |
| Net Income (TTM) | — | $-534,796,000 |
ABBV leads on 1 of 1 size & scale factors.
Valuation
| ABBV | VKTX | |
|---|---|---|
| Price / Book | — | 9.57 |
ABBV and VKTX split the valuation factors evenly.
Profitability
| ABBV | VKTX | |
|---|---|---|
| Return on Equity | — | -130.98% |
ABBV and VKTX split the profitability factors evenly.
Dividend
| ABBV | VKTX | |
|---|---|---|
| Dividend Yield | 2.81% | — |
ABBV and VKTX split the dividend factors evenly.
Risk & Sentiment
| ABBV | VKTX | |
|---|---|---|
| Short Interest | 0.85% | 1.14% |
ABBV leads on 1 of 1 risk & sentiment factors.
Dig deeper: ABBV overview, ABBV financials, VKTX overview, VKTX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.